eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Draft Guidances for Industry; Availability: Bioequivalence Recommendation for Lenalidomide Capsules
Draft Guidances for Industry; Availability: Bioequivalence Recommendation for Lenalidomide Capsules
Document ID:
FDA-2007-D-0433-0008
Document Type:
Notice
Agency:
Food And Drug Administration
Topics:
No Topics associated with this document
Federal Register Number:
2012-27004
View Document:
Details Information
Document Subtype:
Notice of Availability
Received Date:
November 06 2012, at 12:00 AM Eastern Standard Time
Start-End Page:
66621 - 66622
Page Count:
2
Comment Start Date:
November 6 2012, at 12:00 AM Eastern Standard Time
Comment Due Date:
January 7 2013, at 11:59 PM Eastern Standard Time
Comments
Total:
3
March of Dimes Foundation - Comment
Posted:
01/03/2013
ID:
FDA-2007-D-0433-0010
Comment Period Closed
Jan 07,2013 11:59 PM ET
Celgene - Comment
Posted:
01/09/2013
ID:
FDA-2007-D-0433-0011
Comment Period Closed
Jan 07,2013 11:59 PM ET
Society for Women's Health Research (SWHR) - Comment
Posted:
01/23/2013
ID:
FDA-2007-D-0433-0012
Comment Period Closed
Jan 07,2013 11:59 PM ET
Related Documents
Total:
0
No documents available.
Draft Guidances for Industry; Availability: Bioequivalence Recommendation for Lenalidomide Capsules
Details Information
Comments
Posted: 01/03/2013 ID: FDA-2007-D-0433-0010
Jan 07,2013 11:59 PM ET
Posted: 01/09/2013 ID: FDA-2007-D-0433-0011
Jan 07,2013 11:59 PM ET
Posted: 01/23/2013 ID: FDA-2007-D-0433-0012
Jan 07,2013 11:59 PM ET
Related Documents